These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28694463)

  • 1. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
    Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
    Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease.
    Badachhape AA; Working PK; Srivastava M; Bhandari P; Stupin IV; Devkota L; Tanifum EA; Annapragada AV; Ghaghada KB
    Sci Rep; 2020 Sep; 10(1):16185. PubMed ID: 32999398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
    Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
    Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
    Sigurdsson EM; Wadghiri YZ; Mosconi L; Blind JA; Knudsen E; Asuni A; Scholtzova H; Tsui WH; Li Y; Sadowski M; Turnbull DH; de Leon MJ; Wisniewski T
    Neurobiol Aging; 2008 Jun; 29(6):836-47. PubMed ID: 17291630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening.
    Santin MD; Debeir T; Bridal SL; Rooney T; Dhenain M
    Neuroimage; 2013 Oct; 79():288-94. PubMed ID: 23660031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.
    Vanhoutte G; Dewachter I; Borghgraef P; Van Leuven F; Van der Linden A
    Magn Reson Med; 2005 Mar; 53(3):607-13. PubMed ID: 15723413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
    Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
    Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
    Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis.
    Ben-Nejma IRH; Keliris AJ; Vanreusel V; Ponsaerts P; Van der Linden A; Keliris GA
    Alzheimers Res Ther; 2023 Jan; 15(1):23. PubMed ID: 36707887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
    Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
    Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.
    Dhenain M; Delatour B; Walczak C; Volk A
    Magn Reson Med; 2006 Mar; 55(3):687-93. PubMed ID: 16470593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.
    Jack CR; Wengenack TM; Reyes DA; Garwood M; Curran GL; Borowski BJ; Lin J; Preboske GM; Holasek SS; Adriany G; Poduslo JF
    J Neurosci; 2005 Oct; 25(43):10041-8. PubMed ID: 16251453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.
    Wengenack TM; Reyes DA; Curran GL; Borowski BJ; Lin J; Preboske GM; Holasek SS; Gilles EJ; Chamberlain R; Marjanska M; Jack CR; Garwood M; Poduslo JF
    Neuroimage; 2011 Jan; 54(1):113-22. PubMed ID: 20728546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR microimaging of amyloid plaques in Alzheimer's disease transgenic mice.
    Wengenack TM; Jack CR; Garwood M; Poduslo JF
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S82-8. PubMed ID: 18239918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.